CD4 and HIV infectious disease: Given available evidence that these monocyte biomarkers have prognostic significance in the general population as well as among those with HIV infection – including when standard CD4 T cell monitoring approaches carry limited prognostic value in the setting of ‘successful’ therapy [20], [29] – we would suggest that consideration of their inclusion in routine care is warranted.